PellePharm

PellePharm, Inc. operates in the biotechnology industry. The company was incorporated in 2012 and is based in Menlo Park, California. Focused on the development of topical patidegib, a first-in-class topical hedgehog inhibitor, to decrease the number of surgically-eligible basal cell carcinomas (BCCs) in persons with Gorlin Syndrome and those with sporadic BCCs.
Type
Private
HQ
Menlo Park, US
Founded
2012
Size (employees)
5 (est)
PellePharm was founded in 2012 and is headquartered in Menlo Park, US

PellePharm Office Locations

PellePharm has office in Menlo Park
Menlo Park, US

PellePharm Metrics

PellePharm Summary

Founding Date

2012

Total Funding

$11.4 M

Latest funding size

$3.25 M

Time since last funding

6 months
We estimate that PellePharm's latest funding round in August 2016 was $3.25 M. In total, PellePharm has raised $11.4 M

PellePharm Company Life

You may also be interested in